The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1038/s41598-018-26811-9
Published Online: 2018-06-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tong, Hongxuan
Fan, Zhu
Liu, Biyuan
Lu, Tao
Text and Data Mining valid from 2018-06-06
Version of Record valid from 2018-06-06
Article History
Received: 29 September 2017
Accepted: 11 May 2018
First Online: 6 June 2018
Competing Interests
: The authors declare no competing interests.